RGC
Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Limited (RGC) is currently in a downtrend, trading below both the 50-day and 200-day moving averages. RSI is at 25.8 (oversold), with 0/3 trend checks passing.
RGC with MA50 and MA200
Key levels & signals
RGC valuation multiples (TTM)
Regencell Bioscience Holdings Limited (RGC) currently looks weaker on the chart and is not showing much trend strength. The latest available price is $5.13, and 0 of 3 core trend checks are currently passing. Price is trading below the 50-day moving average by 71.6% and below the 200-day moving average by 76.5%.
RGC currently has an RSI reading of 25.8, which suggests weaker momentum and a more oversold condition. Some traders may review this kind of setup for a rebound or buy-the-dip idea, but oversold readings by themselves do not guarantee a reversal.
For traders reviewing RGC next, the main question is whether weakness is starting to stabilise or whether the chart still looks vulnerable to further downside. Some traders may watch for bounce attempts, but others will want to see stronger proof that the trend is improving before treating the stock as a cleaner setup.
About Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Limited is a biotechnology firm specializing in Traditional Chinese Medicine (TCM). Its core activities revolve around the research, development, and market introduction of TCM solutions specifically designed to address neurocognitive disorders and related degeneration. The company places a particular emphasis on conditions such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Established in 2014, Regencell Bioscience maintains its primary office in Causeway Bay, Hong Kong.
RGC shares outstanding over time
Tracking total shares outstanding is one way to spot dilution — a rising line means the company has issued more shares (stock-based compensation, secondary offerings, convertible debt), which spreads the same earnings and ownership across more shares. A falling line usually reflects buybacks.
Learn the indicators behind this page
More stock opportunities
Common questions about RGC
Is this page a buy or sell recommendation?
No. This page is designed to help you review chart structure, momentum and technical context more quickly, but it is not personal financial advice.
Why can a stock look bullish and overbought at the same time?
Strong trending stocks can still become stretched in the short term. That is why trend traders and dip buyers can read the same chart differently.
What should I do next after reading this page?
Open the full dashboard, review the chart in more detail, compare indicators, and decide whether the setup still makes sense within your own process.